These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15329034)

  • 61. Long-term toxic effects of adjuvant chemotherapy in breast cancer.
    Azim HA; de Azambuja E; Colozza M; Bines J; Piccart MJ
    Ann Oncol; 2011 Sep; 22(9):1939-1947. PubMed ID: 21289366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Duration of complete response to chemotherapy in advanced breast cancer.
    Fischer J; Rose CJ; Rubens RD
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):747-54. PubMed ID: 6759140
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug Combinations in Breast Cancer Therapy.
    Fisusi FA; Akala EO
    Pharm Nanotechnol; 2019; 7(1):3-23. PubMed ID: 30666921
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 'Small' randomised neo-adjuvant chemotherapy trials in breast cancer reporting on pathological response: more harm than good?
    Bonnefoi H
    Ann Oncol; 2005 Sep; 16(9):1407-10. PubMed ID: 16076932
    [No Abstract]   [Full Text] [Related]  

  • 65. Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.
    Robain M; Pierga JY; Jouve M; Asselain B; Diéras V; Beuzeboc P; Palangié T; Dorval T; Extra JM; Scholl S; Pouillart P
    Eur J Cancer; 2000 Dec; 36(18):2301-12. PubMed ID: 11094303
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination chemotherapy for breast cancer metastatic to bone marrow.
    Rodriguez-Kraul R; Hortobagyi GN; Buzdar AU; Blumenschein GR
    Cancer; 1981 Jul; 48(2):227-32. PubMed ID: 7237395
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Is primary chemotherapy useful for all patients with primary invasive breast cancer?
    Scholl SM; Beuzeboc P; Harris AL; Pierga JY; Asselain B; Palangié T; Dorval T; Jouve M; Diéras V; Pouillart P
    Recent Results Cancer Res; 1998; 152():217-26. PubMed ID: 9928560
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of chemotherapy dose intensity on cancer patient outcomes.
    Lyman GH
    J Natl Compr Canc Netw; 2009 Jan; 7(1):99-108. PubMed ID: 19176210
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Point: combination versus single-agent chemotherapy: the argument for sequential single agents.
    Conlin AK; Seidman AD
    J Natl Compr Canc Netw; 2007 Sep; 5(8):668-72. PubMed ID: 17927924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High-dose chemotherapy for breast cancer.
    Leonard RC
    Eur J Cancer; 1996 Feb; 32A(2):205-8. PubMed ID: 8664028
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Indications for cytostatic therapy in metastatic breast cancer.
    Kvinnsland S
    Acta Oncol; 1992; 31(2):215-8. PubMed ID: 1622636
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High dose chemotherapy: rationale and results in breast carcinoma.
    Coleman RE
    Cancer; 2000 Jun; 88(12 Suppl):3059-64. PubMed ID: 10898352
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of 5-day, 1-day, and 2-day cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Bates TD; Brinkley D; MacRae KD; Spittle MF; Wheeler T
    Lancet; 1975 Aug; 2(7927):209-11. PubMed ID: 51964
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum sialyl transferase levels in patients with metastatic breast cancer treated by chemotherapy.
    Stewart JF; Rubens RD; Hoare S; Bulbrook RD; Kessel D
    Br J Cancer; 1982 Aug; 46(2):208-12. PubMed ID: 6758827
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Locally advanced noninflammatory breast cancer.
    Swain SM
    Cancer Invest; 1999; 17(3):211-9. PubMed ID: 10099661
    [No Abstract]   [Full Text] [Related]  

  • 76. Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.
    Zimmer AS; Steeg PS
    J Mol Med (Berl); 2015 Jan; 93(1):13-29. PubMed ID: 25412774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-dose chemotherapy for breast cancer.
    de Vries EG; Mastenbroek CC; Rodenhuis S
    Ann Intern Med; 1997 Jun; 126(11):917-8. PubMed ID: 9163302
    [No Abstract]   [Full Text] [Related]  

  • 78. Adjuvant chemotherapy and cancer cure.
    Bertino JR
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):109-13. PubMed ID: 7061245
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The case for high-dose adjuvant chemotherapy in breast cancer: (I) theoretical considerations.
    Cameron DA; Leonard RC
    Eur J Surg Oncol; 1996 Oct; 22(5):540-2. PubMed ID: 8903501
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The importance of dose and schedule in cancer chemotherapy: haematological cancer.
    Sweetenham JW
    Anticancer Drugs; 1995 Oct; 6 Suppl 5():7-15. PubMed ID: 8845497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.